Quick Look at Globus Medical (GMED)

Globus Medical moved -18.47% this afternoon session, trading between a high of $78.58 and a low of $76.96 per share. Yesterday the stock finished at $77.88 per share, compared to an average analyst target price of $78.29.

Globus Medical, Inc., a medical device company, develops and markets healthcare solutions for patients with musculoskeletal disorders. The mid-cap surgical & medical instruments & apparatus company is based in the United States, and doesn't offer a dividend. Globus Medical has trailing twelve months earnings per share (EPS) of 1.47, which at today's prices amounts to a price to earnings (P/E) ratio of 52.35.

Based on its expected future earnings growth, the company has a price to earnings growth (PEG) ratio of 2.928. Usually a PEG ratio between zero and one indicates a potentially undervalued company.

GMED has a revenue per share ratio of 9.9 and an enterprise value to revenue ratio of 7.03, based on its total revenue of $998,366,000. The company's revenues have a year-on-year growth rate of 10.6%, compared to a YoY growth rate of 4.4% for its earnings.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.